Pancreatic Cancer Research

ResearcherKarolinska University HospitalNo recent work listed

Feng Wang

Matched on ORCID iD 0000-0002-2506-9966; OpenAlex author ID A5101905026. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 9

  1. Epigallocatechin-3-Gallate Decreases Hypoxia-Inducible Factor-1 in Pancreatic Cancer Cells. Last author DOI 10.1142/s0192415x23500362↗
  2. Inhibition of hypoxia-induced HIF-1α-mediated autophagy enhances the in vitro antitumor activity of rhein in pancreatic cancer cells. First author DOI 10.1002/jat.4365↗
  3. Caveolin-1 increases glycolysis in pancreatic cancer cells and triggers cachectic states. Last author DOI 10.1096/fj.202100121rrr↗
  4. β-Pentagalloyl-Glucose Sabotages Pancreatic Cancer Cells and Ameliorates Cachexia in Tumor-Bearing Mice. First author DOI 10.1142/s0192415x19500356↗
  5. The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells. Co-author DOI 10.1186/s12885-018-4271-3↗
  6. Emodin and rhein decrease levels of hypoxia-inducible factor-1α in human pancreatic cancer cells and attenuate cancer cachexia in athymic mice carrying these c… Last author DOI 10.18632/oncotarget.21330↗
  7. Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value. Co-author DOI 10.7150/jca.14185↗
  8. Four types of fatty acids exert differential impact on pancreatic cancer growth. Last author DOI 10.1016/j.canlet.2015.02.002↗
  9. Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene. Co-author DOI 10.1371/journal.pone.0043399↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lijuan Hu · 5 shared papers, 2017–2023 · strength 0.64
  2. Chuanshan Yao · 2 shared papers, 2021–2022 · strength 0.46
  3. Shuai Qiu · 3 shared papers, 2019–2023 · strength 0.45
  4. Dapeng Zhang · 3 shared papers, 2015–2023 · strength 0.40
  5. Jing Yang · 1 shared paper, 2019 · strength 0.11
  6. Lihua Cui · 1 shared paper, 2019 · strength 0.11
  7. Wencong Tian · 1 shared paper, 2018 · strength 0.09
  8. Ming Yu · 1 shared paper, 2015 · strength 0.06
  9. De‐Shen Wang · 1 shared paper, 2016 · strength 0.05
  10. Dongsheng Zhang · 1 shared paper, 2016 · strength 0.05
  11. Miao‐Zhen Qiu · 1 shared paper, 2016 · strength 0.05
  12. Feng‐Hua Wang · 1 shared paper, 2016 · strength 0.05
  13. Rui‐Hua Xu · 1 shared paper, 2016 · strength 0.05
  14. Yuhong Li · 1 shared paper, 2016 · strength 0.05
  15. Ming Yu · 1 shared paper, 2012 · strength 0.03
  16. Xiuchao Wang · 1 shared paper, 2012 · strength 0.03
  17. Song Gao · 1 shared paper, 2012 · strength 0.03
  18. Tiansuo Zhao · 1 shared paper, 2012 · strength 0.03
  19. He Ren · 1 shared paper, 2012 · strength 0.03
  20. Jihui Hao · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.